Mass. diagnostics firms sign M & A deals worth $500M

Two local diagnostics firms, one of which is working in the increasingly competitive field of cancer testing, closed acquisition deals this week worth around $500 million.   Billerica-based Quanterix Corp. (Nasdaq: QTRX) announced this week it will buy Swedish firm UmanDiagnostics AB for $22.5 million.  By purchasing Uman, Quanterix will get access to a cache of antibodies that can detect an element called neurofilament light. Quanterix’s commercial diagnostic t ool looks for small amounts of…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news